Lexeo Therapeutics (LXEO) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free LXEO Stock Alerts $13.97 +0.41 (+3.02%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexeo Therapeutics Short Interest DataCurrent Short Volume696,200 sharesPrevious Short Volume836,400 sharesChange Vs. Previous Month-16.76%Dollar Volume Sold Short$8.67 millionShort Interest Ratio / Days to Cover5.9Last Record DateApril 30, 2024Outstanding Shares32,945,000 sharesFloat Size16,040,000 sharesShort Percent of Float4.34%Today's Trading Volume77,448 sharesAverage Trading Volume109,276 sharesToday's Volume Vs. Average71% Short Selling Lexeo Therapeutics ? Sign up to receive the latest short interest report for Lexeo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLXEO Short Interest Over TimeLXEO Days to Cover Over TimeLXEO Percentage of Float Shorted Over Time Ad Chaikin AnalyticsMy system predicted the BA collapse – now it’s issuing an AI warningEven after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... Lexeo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024696,200 shares $8.67 million -16.8%4.3%5.9 $12.45 4/15/2024836,400 shares $10.11 million +6.8%5.2%8.1 $12.09 3/31/2024783,500 shares $12.29 million +63.4%4.9%7.3 $15.68 3/15/2024479,500 shares $7.47 million +41.3%3.0%4.4 $15.57 2/29/2024339,400 shares $4.96 million -3.6%2.1%3.6 $14.62 2/15/2024352,000 shares $5.36 million +16.8%2.8%3.6 $15.22 1/31/2024301,500 shares $5.17 million No Change2.4%2.8 $17.14 LXEO Short Interest - Frequently Asked Questions What is Lexeo Therapeutics' current short interest? Short interest is the volume of Lexeo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 696,200 shares of LXEO short. 4.34% of Lexeo Therapeutics' shares are currently sold short. Learn More on Lexeo Therapeutics' current short interest. What is a good short interest ratio for Lexeo Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXEO shares currently have a short interest ratio of 6.0. Learn More on Lexeo Therapeutics's short interest ratio. What is a good short interest percentage for Lexeo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.34% of Lexeo Therapeutics' floating shares are currently sold short. Is Lexeo Therapeutics' short interest increasing or decreasing? Lexeo Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 696,200 shares, a decline of 16.8% from the previous total of 836,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lexeo Therapeutics' float size? Lexeo Therapeutics currently has issued a total of 32,945,000 shares. Some of Lexeo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexeo Therapeutics currently has a public float of 16,040,000 shares. How does Lexeo Therapeutics' short interest compare to its competitors? 4.34% of Lexeo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Lexeo Therapeutics: Editas Medicine, Inc. (24.93%), Voyager Therapeutics, Inc. (7.74%), Fate Therapeutics, Inc. (19.45%), iTeos Therapeutics, Inc. (7.23%), C4 Therapeutics, Inc. (14.74%), Taysha Gene Therapies, Inc. (9.04%), Ocugen, Inc. (18.61%), Allogene Therapeutics, Inc. (32.03%), Replimune Group, Inc. (19.05%), Valneva SE (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lexeo Therapeutics stock? Short selling LXEO is an investing strategy that aims to generate trading profit from Lexeo Therapeutics as its price is falling. LXEO shares are trading up $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexeo Therapeutics? A short squeeze for Lexeo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LXEO, which in turn drives the price of the stock up even further. How often is Lexeo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXEO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: EDIT Short Interest VYGR Short Interest FATE Short Interest ITOS Short Interest CCCC Short Interest TSHA Short Interest OCGN Short Interest ALLO Short Interest REPL Short Interest VALN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LXEO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company